lymphoma

April 26, 2019

CAR T Cells Can Directly Target Lymphoma in Mice, Study Finds

News

Using an advanced microscopic technique to visualize how CAR T cells work in a mouse model of lymphoma, researchers found that these cells can induce tumor regression by directly targeting ... Read more

March 8, 2019March 8, 2019

Physician Stephen J. Forman Receives Top Honors for Research on Bone Marrow Transplantation

News

Stephen J. Forman, MD, a physician and researcher in bone marrow transplantation and disorders such as lymphoma, is racking up some accolades. Forman will receive the 2019 DKMS Mechtild Harf ... Read more

February 4, 2019

2 Small RNA Molecules Suppress Lymphoma, Leukemia Development, Mouse Study Suggests

News

Two small non-coding RNA molecules — miR-146a and miR-146b — appear to protect against the development of blood cancers such as B-cell lymphoma and acute myeloid leukemia, a mouse study suggests. These ... Read more

October 24, 2018

Leukemia and Lymphoma Society Grants $5M for Development of Blood Cancer Immunotherapies

News

A team of Texas researchers received a grant of $5 million from the Leukemia and Lymphoma Society to develop targeted immunotherapies for blood cancers. The Specialized Center of Research (SCOR) grant will provide ... Read more

October 2, 2018October 2, 2018

Abdominal Obesity Better Than BMI at Predicting Risk for Blood Diseases, Study Shows

News

Measuring abdominal fat (obesity), including waist circumference, is a better predictor of the risk of developing hematological malignancies, especially multiple myeloma, than body mass index (BMI), according to a population-based ... Read more

July 10, 2018

Lymphoma Therapies Kymriah, Yescarta Recommended for Approval in Europe

News

The European Medicines Agency (EMA) has recommended the approval of two lymphoma medications: Kymriah (tisagenlecleucel) and Yescarta (axicabtagene ciloleucel). The EMA’s decision represents the first two recommendations for chimeric antigen receptors ... Read more

April 27, 2018April 27, 2018

FDA Orders Enrollment Hold on Tazemetostat Clinical Trials

News

Patient enrollment for clinical trials of Epizyme’s tazemetostat is temporarily on hold. The decision from the U.S. Food and Drug Administration (FDA) follows a safety report of a pediatric patient ... Read more

April 16, 2018

Blocking a MicroRNA Improves Symptoms of Chronic Graft-versus-Host Disease in Mouse Model

News

Blocking a specific microRNA molecule reduced symptoms of graft-versus-host disease (GVHD) in mouse models of bone marrow transplants, a study shows. Findings from this research, led by investigators at the ... Read more

March 9, 2018March 9, 2018

Antibiotics May Reduce Chemotherapy’s Effectiveness, Study Suggests

News

Using antibiotics in cancer patients may significantly reduce the effectiveness of chemotherapy agents, which appear to require help from the body’s immune system to function, according to a study by researchers ... Read more

March 6, 2018March 6, 2018

Proposed Guideline Urges Caution Prescribing Cannabis in Canada

News

A proposed guideline focusing on the use of cannabinoid medical products says there is some evidence they benefit patients with chemotherapy-induced nausea and vomiting, which is particularly relevant for patients with ... Read more